Condition: Acute Myeloid Leukaemia (AML) · Follicular Lymphoma ( FL) · Sponsor: Tempus AI
The TEMPUS AQUARIUS Study is a non-interventional, longitudinal observational study focused on hematological malignancies. It will collect rich molecular (multi-omic) and clinical data from patient cohorts through serial blood draws and the acquisition of leftover tissue and/or bone marrow aspirates during their routine therapy and disease monitoring. The primary goal is to understand the association between biomarkers and real-world clinical outcomes in these patient populations.
This description comes directly from the study's public registry record.
Aquarius Clinical Study Manager · 800-739-4137 · aquarius@tempus.com
Always discuss trial participation with your own doctor first.
| University of Iowa Hospital and Clinics | Iowa City, Iowa, United States | Recruiting |
| The Center for Cancer and Blood Disorders | Bethesda, Maryland, United States | Recruiting |
| Washington University in St. Louis | St Louis, Missouri, United States | Recruiting |
| Cancer Care Specialists of Reno | Reno, Nevada, United States | Recruiting |
| University of Cincinnati | Cincinnati, Ohio, United States | Recruiting |
| OhioHealth Research Institute | Columbus, Ohio, United States | Recruiting |
| Taylor Cancer Research Center | Maumee, Ohio, United States | Recruiting |
| Cancer Care Associates of York | York, Pennsylvania, United States | Recruiting |
| Avera Cancer Institue | Sioux Falls, South Dakota, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07154823